Department of Radiation Oncology

Low-Dose Radiotherapy is highly effective in the Treatment of painful Finger Polyarthrosis (2021) Weissmann T, Gaipl U, Putz F, Hecht M, Donaubauer AJ, Zhou J, Fietkau R, et al. Conference contribution The Growth of primary and abscopal Tumors as well as their immunological Microenvironment are differently influenced by different Combinations of Radiation and Immunotherapies (2021) Rückert M, Deloch L, Frey B, Fietkau R, Gaipl U Conference contribution Progress Patterns under Radioimmunotherapy - clinical Evaluation of the prospective STICI Study (2021) Schubert P, Schweizer C, Roesch J, Haderlein M, Rutzner S, Semrau S, Donaubauer AJ, et al. Conference contribution Effect of the AMPA Receptor Inhibitor Perampanel in Combination Therapy with ionizing Radiation on Glioblastoma Cells and Fibroblasts (2021) Knabe A, Stritzelberger J, Fietkau R, Distel L Conference contribution Influence of CDK4/6 Inhibitors and Ionizing Radiation on Senescence in Breast Cancer Cells (2021) Quarz L, Jost T, Fietkau R, Distel L Conference contribution In regard to “The Italian association of radiotherapy and oncology recommendation for breast tumor recurrence: grades of recommendation, assessment, development and evaluation criteria” (2021) Hannoun-Levi JM, Gutierrez C, Polgar C, Strnad V Journal article In Vitro Examinations of Cell Death Induction and the Immune Phenotype of Cancer Cells Following Radiative-Based Hyperthermia with 915 MHz in Combination with Radiotherapy (2021) Hader M, Streit S, Rosin A, Gerdes T, Wadepohl M, Bekeschus S, Fietkau R, et al. Journal article Kinase Inhibitors of DNA-PK, ATM and ATR in Combination with Ionizing Radiation Can Increase Tumor Cell Death in HNSCC Cells While Sparing Normal Tissue Cells (2021) Faulhaber EM, Jost T, Symank JA, Scheper J, Burkel F, Fietkau R, Hecht M, Distel L Journal article Prediction of response to Certolizumab-Pegol in rheumatoid arthritis (PreCePRA) by functional MRI of the brain – Study protocol for a randomized double-blind controlled study (2021) Schenker H, Tascilar K, Konerth L, Sergeeva M, Prade J, Strobelt S, Kleyer A, et al. Journal article PARP Inhibitors Talazoparib and Niraparib Sensitize Melanoma Cells to Ionizing Radiation (2021) Jonuscheit S, Jost T, Gajdošová F, Wrobel M, Hecht M, Fietkau R, Distel L Journal article